Published in Eur J Orthod on August 01, 1990
Mechanisms of tooth eruption and orthodontic tooth movement. J Dent Res (2008) 2.09
The efficacy of different pre- and post-operative analgesics in the management of pain after orthodontic separator placement: A randomized clinical trial. J Pharm Bioallied Sci (2014) 0.77
Increase of CGRP-containing nerve fibers in the rat periodontal ligament after luxation. Cell Mol Neurobiol (2011) 0.77
Restorative complications of orthodontic treatment. Br Dent J (2016) 0.75
Orthodontic treatment induced temporal alteration of jaw-opening reflex excitability. J Neurophysiol (2017) 0.75
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet (1997) 1.94
Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment. Cancer Res (1989) 1.91
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat (1999) 1.63
Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. N Engl J Med (1990) 1.48
Identification of 4-hydroxy-N-desmethyltamoxifen as a metabolite of tamoxifen in human bile. Cancer Res (1988) 1.45
Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women. Int J Cancer (1990) 1.34
Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study. Clin Cancer Res (1997) 1.22
Improved measurement of androgen receptors in human breast cancer. Cancer Res (1989) 1.20
Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Eur J Surg Oncol (1992) 1.15
Widowhood and divorce related to cancer risk in middle-aged women. A nested case-control study among Norwegian women born between 1935 and 1954. Int J Cancer (1994) 1.12
Body height and risk of breast cancer. A prospective study of 23,831 Norwegian women. Br J Cancer (1990) 1.11
Death of a husband or marital divorce related to risk of breast cancer in middle-aged women. A nested case-control study among Norwegian women born 1935-1954. Eur J Cancer (1994) 1.07
1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed (1994) 1.07
Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer. Breast Cancer Res Treat (1983) 1.02
Health technology assessment and implications for clinical practice: the case of prostate cancer screening. Scand J Clin Lab Invest (2003) 1.00
Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer. Drugs (1988) 0.99
In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue. Anticancer Res (1994) 0.99
Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer (1996) 0.98
Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study. Eur J Cancer (1991) 0.97
The leucocyte nadir, a predictor of chemotherapy efficacy? Br J Cancer (1999) 0.94
Aminoglutethimide and warfarin. A new important drug interaction. Cancer Chemother Pharmacol (1984) 0.93
Pregnancy-related factors and risk of breast cancer in a prospective study of 29,981 Norwegian women. Eur J Cancer (1992) 0.93
Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. J Clin Pathol (1992) 0.93
Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings. Clin Pharmacokinet (1987) 0.91
Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study. Eur J Surg Oncol (2002) 0.90
Prospective study of height, body mass index and risk of breast cancer. Acta Oncol (1992) 0.90
Does early physical maturity influence breast cancer risk? Acta Oncol (1994) 0.90
Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial. Eur J Cancer Clin Oncol (1986) 0.87
Cigarette smoking and risk of breast cancer: a prospective study of 24,329 Norwegian women. Eur J Cancer (1990) 0.87
Progesterone-binding cyst protein in human breast tumor cytosol. Cancer Res (1987) 0.87
Plasma changes in breast cancer patients during endocrine therapy--lipid measurements and nuclear magnetic resonance (NMR) spectroscopy. Breast Cancer Res Treat (1995) 0.87
Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. Clin Pharmacokinet (1992) 0.86
Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging (1994) 0.85
Epithelial restitution and cellular proliferation after gastric mucosal damage caused by hypertonic NaCl in rats. Virchows Arch A Pathol Anat Histopathol (1988) 0.85
Partial resection of the cartilaginous nasal septum in rats; its influence on growth. Angle Orthod (1974) 0.85
Protein kinases activated by cAMP in the genital tract of spayed mice treated with oestradiol-17beta. J Reprod Fertil (1975) 0.84
Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at risk. Anticancer Res (1996) 0.83
Single-dose and steady-state pharmacokinetics of aminoglutethimide. Clin Pharmacokinet (1985) 0.83
Cytosol albumin content in operable breast cancer. Correlations to steroid hormone receptors, other prognostic factors and prognosis. Acta Oncol (1991) 0.83
Quality of life of cancer patients with different prognoses. Qual Life Res (1994) 0.83
Determination of tamoxifen and four metabolites in serum by low-dispersion liquid chromatography. Clin Chem (1987) 0.83
Immunocompetent cells in rat periodontal ligament and their recruitment incident to experimental orthodontic tooth movement. Eur J Oral Sci (1997) 0.82
The influence of progestins on receptor levels in breast cancer metastasis. Anticancer Res (1987) 0.82
The sagittal growth of the foetal cranial base. Acta Odontol Scand (1971) 0.81
Regional variations in cell proliferation and matrix formation in the cartilaginous nasal septum of the rat. [3H]-Thymidine and [35S]-sulfate incorporation studies. Growth (1977) 0.81
Determination of warfarin in human plasma by high performance liquid chromatography and photodiode array detector. Ther Drug Monit (1985) 0.81
Growth in craniofacial cartilages studied by 3H-thymidine incorporation. Growth (1975) 0.81
Cytosol protein content and prognosis in operable breast cancer. Correlations with steroid hormone receptors and other prognostic factors. Breast Cancer Res Treat (1991) 0.81
Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer. Clin Pharmacol Ther (1984) 0.81
Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas. Acta Oncol (1999) 0.81
Effect of experimental tooth movement on periodontal and pulpal blood flow. Eur J Orthod (1989) 0.80
The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer. Cancer Chemother Pharmacol (1986) 0.80
The relationship between the cartilaginous nasal septum and maxillary growth during human fetal life. Cleft Palate J (1970) 0.80
Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Res (1986) 0.80
Weekly Adriamycin vs. 4-epidoxorubicin every second week in advanced breast cancer. A randomized trial. The Norwegian Breast Cancer Group. Eur J Cancer (1990) 0.80
Effect of salt-induced mucosal damage and healing on penetration of N-methyl-N'-nitro-N-nitrosoguanidine to proliferative cells in the gastric mucosa of rats. Carcinogenesis (1994) 0.80
Effect of experimental tooth movement on nerve fibres immunoreactive to calcitonin gene-related peptide, protein gene product 9.5, and blood vessel density and distribution in rats. Eur J Orthod (1997) 0.80
Measurement of adenylate cyclase activity by competitive binding to the free regulatory moiety of protein kinase I. Int J Biochem (1980) 0.80
Blood flow and mucoid cap protect against penetration of carcinogens into superficially injured gastric mucosa of rats. Dig Dis Sci (1995) 0.79
[The radiotherapy satellite in Kristiansand--a model for Norwegian regional hospitals?]. Tidsskr Nor Laegeforen (2001) 0.79
Autogenous transplantation of the nasal septum cartilage in the rat. Arch Oral Biol (1974) 0.79
CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer--a phase I study. Ann Oncol (1990) 0.79
The sagittal growth of the upper face during foetal life. Acta Odontol Scand (1971) 0.79
Value of sonography in obstructive jaundice. Limitations of bile duct caliber as an index of obstruction. Scand J Gastroenterol (1987) 0.79
Penetration of N-methyl-N'-nitro-N-nitrosoguanidine to proliferative cells in gastric mucosa of rats is different in pylorus and fundus and depends on exposure time and solvent. Carcinogenesis (1993) 0.79
Treatment of breast carcinoma with aminoglutethimide. Acta Radiol Oncol (1984) 0.78
Matrix formation in the mandibular condyle of the rat (35S) - sulfate incorporation studies. Acta Odontol Scand (1979) 0.78
Matrix formation in craniofacial cartilages of the rat. [35S]-sulfate incorporation studies. Acta Odontol Scand (1979) 0.78
Bone atrophy and hypergravity in mice. Growth (1974) 0.78
Chemotherapy with or without high-dose medroxyprogesterone acetate in oestrogen-receptor-negative advanced breast cancer. Norwegian Breast Cancer Group. Eur J Cancer (1992) 0.78
Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in postmenopausal patients with breast cancer. J Endocrinol (1995) 0.78
Changes in blood circulation in teeth and supporting tissues incident to experimental tooth movement. Eur J Orthod (1994) 0.78
Regeneration of the cartilaginous nasal septum in the rat, after resection. Its influence on facial growth. Plast Reconstr Surg (1973) 0.78
Role of blood flow in protection against penetration of carcinogens into normal and healing rat gastric mucosa. Dig Dis Sci (1995) 0.77
Adenylate cyclase cytochemistry: a methodological evaluation. Histochem J (1979) 0.77
Inhibitory activity of cartilage growth in serum of young rats. Acta Anat (Basel) (1984) 0.77
Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast. Anticancer Res (1991) 0.77
Progesterone-binding cyst protein (PBCP) in operable breast cancer: correlations with prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Anticancer Res (1991) 0.77
Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor? Breast Cancer Res Treat (1987) 0.77
Progesterone binding cyst protein in hormone receptor positive breast cancer; a predictive factor for effect of adjuvant tamoxifen treatment. Anticancer Res (1995) 0.77
Determination of aminoglutethimide and N-acetylaminoglutethimide in human plasma by reversed-phase liquid chromatography. Ther Drug Monit (1984) 0.77
Growth potential of autografts of cartilage from the nasal septum in the rat. Plast Reconstr Surg (1973) 0.77
Methylthioadenosine phosphorylase in human breast cancer. Breast Cancer Res Treat (1987) 0.77
Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer. Cancer Chemother Pharmacol (1990) 0.77
Glutathione modulation changes the penetration of N-[3H]methyl-N-nitro-N-nitrosoguanidine into gastric mucosa of rats. Dig Dis Sci (1999) 0.77
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--I. General findings. J Steroid Biochem (1990) 0.76
Megestrol acetate versus aminoglutethimide for metastatic breast cancer. Breast Cancer Res Treat (1989) 0.76
Contrast-enhanced magnetic resonance imaging of the breast. Acta Oncol (1992) 0.76
Growth in height of autotransplanted nasal septum in the rat. Its correlation to increase in height of the upper face. Acta Odontol Scand (1973) 0.76
[Mistletoe in the treatment of cancer]. Tidsskr Nor Laegeforen (1993) 0.75
Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer. Breast Cancer Res Treat (1990) 0.75
Effect of inferior alveolar nerve axotomy on periodontal and pulpal blood flow subsequent to experimental tooth movement in rats. Acta Odontol Scand (1998) 0.75
Droloxifene--a new anti-estrogen. A phase II study in advanced breast cancer. Acta Oncol (1992) 0.75
[Screening for early diagnosis of prostatic cancer]. Tidsskr Nor Laegeforen (1994) 0.75
Observations on the early ossification process of the mandible as seen in plastic embedded human embryos. Acta Odontol Scand (1969) 0.75
Effects of dental trauma on pulpal and periodontal nerve morphology. Proc Finn Dent Soc (1992) 0.75
Teamwork in the treatment of cleft lips and palates. Acta Paediatr Scand (1967) 0.75